Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Innis, RB' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 172 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Staley, JK; Van Dyck, CH; Tan, PZ; Al Tikriti, M; Ramsby, Q; Klump, H; Ng, C; Garg, P; Soufer, R; Baldwin, RM; Innis, RB
      Comparison of [F-18]altanserin and [F-18]deuteroaltanserin for PET imagingof serotonin(2A) receptors in baboon brain: pharmacological studies

      NUCLEAR MEDICINE AND BIOLOGY
    2. Zoghbi, SS; Tamagnan, G; Fujita, M; Baldwin, RM; Al-Tikriti, MS; Amici, L; Seibyl, JP; Innis, RB
      Measurement of plasma metabolites of (S)-5-[I-123]iodo-3-(2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primates

      NUCLEAR MEDICINE AND BIOLOGY
    3. Martinez, D; Gelernter, J; Abi-Dargham, A; van Dyck, CH; Kegeles, L; Innis, RB; Laruelle, M
      The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporterphenotype in humans

      NEUROPSYCHOPHARMACOLOGY
    4. Staley, JK; Krishnan-Sarin, S; Zoghbi, S; Tamagnan, G; Fujita, M; Seibyl, JP; Maciejewski, PK; O'Malley, S; Innis, RB
      Sex differences in [I-123]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers

      SYNAPSE
    5. Varrone, A; Marek, KL; Jennings, D; Innis, RB; Seibyl, JP
      [I-123]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy

      MOVEMENT DISORDERS
    6. Charney, DS; Innis, RB; Nestler, EJ; Manji, HK
      Update: What's new in Biological Psychiatry

      BIOLOGICAL PSYCHIATRY
    7. van Dyck, CH; Soares, JC; Tan, PZ; Staley, JK; Baldwin, RM; Amici, LA; Fu, X; Garg, PK; Seibyl, JP; Charney, DS; Innis, RB
      Equilibrium modeling of 5-HT2A receptors with [F-18]deuteroaltanserin and PET: Feasibility of a constant infusion paradigm

      NUCLEAR MEDICINE AND BIOLOGY
    8. Staley, JK; Tamagnan, G; Baldwin, RM; Fujita, M; Al Tikriti, MS; Eshima, L; Thornback, J; Roe, D; Lu, L; Seibyl, JP; Innis, RB
      SPECT imaging with the D-4 receptor antagonist L-750,667 in nonhuman primate brain

      NUCLEAR MEDICINE AND BIOLOGY
    9. Scanley, BE; Gandelman, MS; Laruelle, M; Al-Tikriti, MS; Baldwin, RM; Zoghbi, SS; Hoffer, PB; Wang, S; Neumeyer, JL; Innis, RB
      [I-123]IPCIT and [I-123]beta-CIT as SPECT tracers for the dopamine transporter: A comparative analysis in nonhuman primates

      NUCLEAR MEDICINE AND BIOLOGY
    10. Tamagnan, G; Baldwin, RM; Kula, NS; Baldessarini, RJ; Innis, RB
      Synthesis and monoamine transporter affinity of 2 beta-carbomethoxy-3 beta-(2 ''-, 3 ''- or 4 ''-substituted) biphenyltropanes

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    11. Tamagnan, G; Baldwin, RM; Kula, NS; Baldessarini, RJ; Innis, RB
      Cyclopentadienyltricarbonylrheniumbenzazepines: Synthesis and binding affinity

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    12. Kugaya, A; Fujita, M; Innis, RB
      Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders

      ANNALS OF NUCLEAR MEDICINE
    13. Castner, SA; Al-Tikriti, MS; Baldwin, RM; Seibyl, JP; Innis, RB; Goldman-Rakic, PS
      Behavioral changes and [I-123]IBZM equilibrium SPECT measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamine

      NEUROPSYCHOPHARMACOLOGY
    14. Fujita, M; Innis, RB
      Nuclear psychiatry: specialty for the twenty-first century?

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    15. van Dyck, CH; Malison, RT; Seibyl, JP; Laruelle, M; Klumpp, H; Zoghbi, SS; Baldwin, RM; Innis, RB
      Age-related decline in central serotonin transporter availability with [I-123]beta-CIT SPECT

      NEUROBIOLOGY OF AGING
    16. Fujita, M; Tamagnan, G; Zoghbi, SS; Al-Tikriti, MS; Baldwin, RM; Seibyl, JP; Innis, RB
      Measurement of alpha(4)beta(2) nicotinic acetylcholine receptors with [I-123]5-I-A-85380 SPECT

      JOURNAL OF NUCLEAR MEDICINE
    17. Varrone, A; Fujita, M; Verhoeff, NPLG; Zoghbi, SS; Baldwin, RM; Rajeevan, N; Charney, DS; Seibyl, JP; Innis, RB
      Test-retest reproducibility of extrastriatal dopamine D-2 receptor imagingwith [I-123]epidepride SPECT in humans

      JOURNAL OF NUCLEAR MEDICINE
    18. van Dyck, CH; Tan, PZ; Baldwin, RM; Amici, LA; Garg, PK; Ng, CK; Soufer, R; Charney, DS; Innis, RB
      PET quantification of 5-HT2A receptors in the human brain: A constant infusion paradigm with [F-18]altanserin

      JOURNAL OF NUCLEAR MEDICINE
    19. Mukhin, AG; Gundisch, D; Horti, AG; Koren, AO; Tamagnan, G; Kimes, AS; Chambers, J; Vaupel, DB; King, SL; Picciotto, MR; Innis, RB; London, ED
      5-iodo-A-85380, an alpha 4 beta 2 subtype-selective ligand for nicotinic acetylcholine receptors

      MOLECULAR PHARMACOLOGY
    20. Fujita, M; Verhoeff, NPLG; Varrone, A; Zoghbi, SS; Baldwin, RM; Jatlow, PA; Anderson, GM; Seibyl, JP; Innis, RB
      Imaging extrastriatal dopamine D-2 receptor occupancy by endogenous dopamine in healthy humans

      EUROPEAN JOURNAL OF PHARMACOLOGY
    21. Fujita, M; Charney, DS; Innis, RB
      Imaging serotonergic neurotransmission in depression: Hippocampal pathophysiology may mirror global brain alterations

      BIOLOGICAL PSYCHIATRY
    22. Bremner, JD; Innis, RB; White, T; Fujita, M; Silbersweig, D; Goddard, AW; Staib, L; Stern, E; Cappiello, A; Woods, S; Baldwin, R; Charney, DS
      SPECT [I-123]Iomazenil measurement of the benzodiazepine receptor in panicdisorder

      BIOLOGICAL PSYCHIATRY
    23. Anand, A; Verhoeff, P; Seneca, N; Zoghbi, SS; Seibyl, JP; Charney, DS; Innis, RB
      Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients

      AMERICAN JOURNAL OF PSYCHIATRY
    24. Bremner, JD; Innis, RB; Southwick, SM; Staib, L; Zoghbi, S; Charney, DS
      Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder

      AMERICAN JOURNAL OF PSYCHIATRY
    25. Jacobsen, LK; Staley, JK; Malison, RT; Zoghbi, SS; Seibyl, JP; Kosten, TR; Innis, RB
      Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients

      AMERICAN JOURNAL OF PSYCHIATRY
    26. Jacobsen, LK; Staley, JK; Zoghbi, S; Seibyl, JP; Kosten, TR; Innis, RB; Gelernter, J
      Prediction of dopamine transporter binding availability by genotype: A preliminary report

      AMERICAN JOURNAL OF PSYCHIATRY
    27. Tan, PZ; Baldwin, RM; Van Dyck, CH; Al-Tikriti, M; Roth, B; Khan, N; Charney, DS; Innis, RB
      Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [F-18]altanserin in human and rodent

      NUCLEAR MEDICINE AND BIOLOGY
    28. Tan, PZ; Baldwin, RM; Soufer, R; Garg, PK; Charney, DS; Innis, RB
      A complete remote-control system for reliable preparation of [F-18]altanserin

      APPLIED RADIATION AND ISOTOPES
    29. Verhoeff, NPLG; Soares, JC; D'Souza, CD; Gil, R; Degen, K; Abi-Dargham, A; Zoghbi, SS; Fujita, M; Rajeevan, N; Seibyl, JP; Krystal, JH; van Dyck, CH; Charney, DS; Innis, RB
      [I-123]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia

      PSYCHIATRY RESEARCH-NEUROIMAGING
    30. Bremner, JD; Baldwin, R; Horti, A; Staib, LH; Ng, CK; Tan, PZ; Zea-Ponce, Y; Zoghbi, S; Seibyl, JP; Soufer, R; Charney, DS; Innis, RB
      Quantitation of benzodiazepine receptor binding with PET [C-11]iomazenil and SPECT [I-123]iomazenil: preliminary results of a direct comparison in healthy human subjects

      PSYCHIATRY RESEARCH-NEUROIMAGING
    31. Abi-Dargham, A; Laruelle, M; Krystal, J; D'Souza, C; Zoghbi, S; Baldwin, RM; Seibyl, J; Mawlawi, O; de Erasquin, G; Charney, D; Innis, RB
      No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    32. Fujita, M; Seibyl, JP; Verhoeff, NPLG; Ichise, M; Baldwin, RM; Zoghbi, SS; Burger, C; Staley, JK; Rajeevan, N; Charney, DS; Innis, RB
      Kinetic and equilibrium analyses of [I-123]epidepride binding to striatal and extrastriatal dopamine D-2 receptors

      SYNAPSE
    33. Innis, RB; Marek, KL; Sheff, K; Zoghbi, S; Castronuovo, J; Feigin, A; Seibyl, JP
      Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [I-123]beta-CIT

      MOVEMENT DISORDERS
    34. Tan, PZ; Baldwin, RM; Fu, T; Charney, DS; Innis, RB
      Rapid synthesis of F-18 and H-2 dual-labeled altanserin, a metabolically resistant PET ligand for 5-HT2A receptors

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    35. Ichise, M; Fujita, M; Seibyl, JP; Verhoeff, NPLG; Baldwin, RM; Zoghbi, SS; Rajeevan, N; Charney, DS; Innis, RB
      Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D-2 receptor binding with [I-123]epidepride SPECT

      JOURNAL OF NUCLEAR MEDICINE
    36. Fujita, M; Woods, SW; Verhoeff, NPLG; Abi-Dargham, A; Baldwin, RM; Zoghbi, SS; Soares, JC; Jatlow, PA; Krystal, JH; Rajeevan, N; Charney, DS; Seibyl, JP; Innis, RB
      Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans

      EUROPEAN JOURNAL OF PHARMACOLOGY
    37. Verhoeff, NPLG; Petroff, OAC; Hyder, F; Zoghbi, SS; Fujita, M; Rajeevan, N; Rothman, DL; Seibyl, JP; Mattson, RH; Innis, RB
      Effects of vigabatrin on the GABAergic system as determined by [I-123]iomazenil SPECT and GABA MRS

      EPILEPSIA
    38. Charney, DS; Innis, RB; Nestler, EJ
      New requirements for manuscripts submitted to Biological Psychiatry: Informed consent and protection of subjects

      BIOLOGICAL PSYCHIATRY
    39. Soares, JC; Innis, RB
      Neurochemical brain imaging investigations of schizophrenia

      BIOLOGICAL PSYCHIATRY
    40. Charney, DS; Innis, RB; Nestler, EJ; Davis, KL; Nemeroff, CB; Weinberger, DR
      Increasing public trust and confidence in psychiatric research

      BIOLOGICAL PSYCHIATRY
    41. LARUELLE M; GELERNTER J; INNIS RB
      D-2 RECEPTORS BINDING POTENTIAL IS NOT AFFECTED BY TAQ1 POLYMORPHISM AT THE D-2 RECEPTOR GENE

      Molecular psychiatry
    42. MALISON RT; INNIS RB; LARUELLE M
      RE - LOGAN ET-AL., 1997

      Synapse
    43. KENNAN RP; SCANLEY BE; INNIS RB; GORE JC
      PHYSIOLOGICAL-BASIS FOR BOLD MR SIGNAL CHANGES DUE TO NEURONAL STIMULATION - SEPARATION OF BLOOD-VOLUME AND MAGNETIC-SUSCEPTIBILITY EFFECTS

      Magnetic resonance in medicine
    44. SEIBYL JP; MAREK K; SHEFF K; ZOGHBI S; BALDWIN RM; CHARNEY DS; VANDYCK CH; INNIS RB
      IODINE-123-BETA-CIT AND IODINE-123-FPCIT SPECT MEASUREMENT OF DOPAMINE TRANSPORTERS IN HEALTHY-SUBJECTS AND PARKINSONS PATIENTS

      The Journal of nuclear medicine
    45. FUJITA M; WOODS SW; VERHOEFF NP; ABIDARGHAM A; SOARES JC; JATLOW PA; BALDWIN RM; ZOGHBI SS; SEIBYL JP; RAJEEVAN N; KRYSTAL JH; INNIS RB
      CHANGES OF BENZODIAZEPINE RECEPTOR AND DEVELOPMENT OF TOLERANCE DURING CHRONIC BENZODIAZEPINE ADMINISTRATION IN HEALTHY-HUMAN SUBJECTS

      The Journal of nuclear medicine
    46. VARRONE A; INNIS RB; MAREK K; ZOGHBI S; BALDWIN R; SEIBYL JP
      EVALUATION OF PATIENTS WITH PARKINSONISM WITH [I-123] IBF AND BETA-CIT SPECT

      The Journal of nuclear medicine
    47. TAN PZ; SOARES J; BALDWIN RM; VANDYCK C; SOUFER R; SEIBYL JP; CHARNEY DS; INNIS RB
      H-2 AND F-18 DUAL-LABELED ALTANSERIN AS A METABOLICALLY RESISTANT PETLIGAND FOR SEROTONIN-2A (5-HT2A) RECEPTOR

      The Journal of nuclear medicine
    48. VERHOEFF NPLG; PETROFF OAC; HYDER F; ZOGHBI SS; BALDWIN RM; FUJITA M; RAJEEVAN N; SEIBYL JP; MATTSON R; INNIS RB
      EFFECTS OF VIGABATRIN ON THE GABAERGIC SYSTEM AS DETERMINED BY [I-123] IOMAZENIL SPECT AND GABA MRS

      The Journal of nuclear medicine
    49. RAJEEVAN N; ZUBAL IG; RAMSBY Q; ZOGHBI SS; SEIBYL JP; INNIS RB
      SIGNIFICANCE OF NONUNIFORM ATTENUATION CORRECTION IN QUANTITATIVE BRAIN I-123 SPECT IMAGING

      The Journal of nuclear medicine
    50. MALISON RT; PRICE LH; BERMAN R; PELTON GH; CARPENTER L; SANACORA G; OWENS MJ; NEMEROFF CB; RAJEEVAN N; BALDWIN RM; SEIBYL JP; INNIS RB; CHARNEY DS
      REDUCED MIDBRAIN SEROTONIN TRANSPORTER BINDING IN MAJOR DEPRESSION ASMEASURED BY [I-123] BETA-CIT SPECT

      The Journal of nuclear medicine
    51. ICHISE M; FUJITA M; SEIBYL JP; VERHOEFF NP; BALDWIN RM; ZOGHBI SS; RAJEEVAN N; CHARNEY DS; INNIS RB
      GRAPHICAL MODELING OF DOPAMINE D2 RECEPTOR-BINDING OF 1-123-EPIDEPRIDE TO ACCOUNT FOR LABELED LIPOPHILIC METABOLITES

      The Journal of nuclear medicine
    52. VERHOEFF NPLG; SOARES JC; DSOUZA CD; GIL R; DEGEN K; WEXLER B; ABIDARGHAM A; BALDWIN RM; ZOGHBI SS; FUJITA M; RAJEEVAN N; SEIBYL JP; KRYSTAL JH; INNIS RB
      BENZODIAZEPINE RECEPTOR IMAGING USING [I-123] IOMAZENIL SPECT IN SCHIZOPHRENIA

      The Journal of nuclear medicine
    53. VANDYCK CH; TAN PZ; STALEY J; BALDWIN RM; ALTIKRITI M; GARG PK; NG CK; SOUFER R; CHARNEY DS; INNIS RB
      PET QUANTIFICATION OF 5-HT2A RECEPTORS - A CONSTANT INFUSION PARADIGMWITH [F-18] ALTANSERIN

      The Journal of nuclear medicine
    54. BREMNER JD; INNIS RB; WHITE T; FUJITA M; SILBERSWEIG D; GODDARD A; STAIB L; CAPPIELLO A; WOODS SW; BALDWIN R; CHARNEY DS
      SPECT MEASUREMENT OF BENZODIAZEPINE RECEPTOR-BINDING IN ANXIETY DISORDERS

      The Journal of nuclear medicine
    55. FUJITA M; VERHOEFF NP; BALDWIN RM; ZOGHBI SS; RAJEEVAN N; SEIBYL JP; INNIS RB
      REPRODUCIBILITY OF [I-123] IOMAZENIL EQUILIBRIUM MEASUREMENT OF BENZODIAZEPINE RECEPTORS

      The Journal of nuclear medicine
    56. BREMNER JD; BALDWIN R; STAIB L; NG CK; HORTI A; SEIBYL JP; TAN P; ZEAPONCE Y; SOUFER R; CHARNEY DS; INNIS RB
      PET AND SPECT QUANTITATION OF BENZODIAZEPINE RECEPTOR-BINDING - A DIRECT HEAD-TO-HEAD COMPARISON

      The Journal of nuclear medicine
    57. RAJEEVAN N; ZUBAL IG; RAMSBY SQ; ZOGHBI SS; SEIBYL J; INNIS RB
      SIGNIFICANCE OF NONUNIFORM ATTENUATION CORRECTION IN QUANTITATIVE BRAIN SPECT IMAGING

      The Journal of nuclear medicine
    58. ELSWORTH JD; BRITTAN MS; TAYLOR JR; SLADEK JR; REDMOND DE; INNIS RB; ZEAPONCE Y; ROTH RH
      UP-REGULATION OF STRIATAL D2 RECEPTORS IN THE MPTP-TREATED VERVET MONKEY IS REVERSED BY GRAFTS OF FETAL VENTRAL MESENCEPHALON - AN AUTORADIOGRAPHIC STUDY

      Brain research
    59. STALEY JK; MALISON RT; INNIS RB
      IMAGING OF THE SEROTONERGIC SYSTEM - INTERACTIONS OF NEUROANATOMICAL AND FUNCTIONAL ABNORMALITIES OF DEPRESSION

      Biological psychiatry
    60. INNIS RB; NESTLER EJ; CHARNEY DS
      NEW RESEARCH SERIES

      Biological psychiatry
    61. MALISON RT; PRICE LH; BERMAN R; VANDYCK CH; PELTON GH; CARPENTER L; SANACORA G; OWENS MJ; NEMEROFF CB; RAJEEVAN N; BALDWIN RM; SEIBYL JP; INNIS RB; CHARNEY DS
      REDUCED BRAIN-SEROTONIN TRANSPORTER AVAILABILITY IN MAJOR DEPRESSION AS MEASURED BY [I-123] 2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE AND SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY

      Biological psychiatry
    62. CHARNEY DS; INNIS RB; NESTLER EJ
      NEW LEADERSHIP FOR BIOLOGICAL PSYCHIATRY

      Biological psychiatry
    63. ANAND A; INNIS RB; SEIBYL JP; MAREK KL; CHARNEY DS
      BRAIN SPECT IMAGING IN PARKINSONS-DISEASE ASSOCIATED WITH DEPRESSION

      Biological psychiatry
    64. ABIDARGHAM A; GIL R; KRYSTAL J; BALDWIN RM; SEIBYL JP; BOWERS M; VANDYCK CH; CHARNEY DS; INNIS RB; LARUELLE M
      INCREASED STRIATAL DOPAMINE TRANSMISSION IN SCHIZOPHRENIA - CONFIRMATION IN A 2ND COHORT

      The American journal of psychiatry
    65. MALISON RT; BEST SE; VANDYCK CH; MCCANCE EF; WALLACE EA; LARUELLE M; BALDWIN RM; SEIBYL JP; PRICE LH; KOSTEN TR; INNIS RB
      ELEVATED STRIATAL DOPAMINE TRANSPORTERS DURING ACUTE COCAINE ABSTINENCE AS MEASURED BY [I-123] BETA-CIT SPECT

      The American journal of psychiatry
    66. ABIDARGHAM A; KRYSTAL JH; ANJILVEL S; SCANLEY BE; ZOGHBI S; BALDWIN RM; RAJEEVAN N; ELLIS S; PETRAKIS IL; SEIBYL JP; CHARNEY DS; LARUELLE M; INNIS RB
      ALTERATIONS OF BENZODIAZEPINE RECEPTORS IN TYPE-II ALCOHOLIC SUBJECTSMEASURED WITH SPECT AND [I-123] IOMAZENIL

      The American journal of psychiatry
    67. MALISON RT; MCCANCE E; CARPENTER LL; BALDWIN RM; SEIBYL JP; PRICE LH; KOSTEN TR; INNIS RB
      [I-123] BETA-CIT SPECT IMAGING OF DOPAMINE TRANSPORTER AVAILABILITY AFTER MAZINDOL ADMINISTRATION IN HUMAN COCAINE ADDICTS

      Psychopharmacology
    68. ZEAPONCE Y; BALDWIN RM; STRATTON MD; ALTIKRITI M; SOUFER R; SCHAUS JM; INNIS RB
      RADIOSYNTHESIS AND PET IMAGING OF [N-METHYL-C-11]LY257327 AS A TRACERFOR 5-HT TRANSPORTERS

      Nuclear medicine and biology
    69. LARUELLE M; ABIDARGHAM A; KRYSTAL JH; CHARNEY DS; INNIS RB
      IN-VIVO EVALUATION OF DOPAMINE SYNAPTIC FUNCTION IN UNTREATED SCHIZOPHRENIC-PATIENTS

      Schizophrenia research
    70. LARUELLE M; DSOUZA CD; BALDWIN RM; ABIDARGHAM A; KANES SJ; FINGADO CL; SEIBYL JP; ZOGHBI SS; BOWERS MB; JATLOW P; CHARNEY DS; INNIS RB
      IMAGING D-2 RECEPTOR OCCUPANCY BY ENDOGENOUS DOPAMINE IN HUMANS

      Neuropsychopharmacology
    71. LARUELLE M; IYER RN; ALTIKRITI MS; ZEAPONCE Y; MALISON R; ZOGHBI SS; BALDWIN RM; KUNG HF; CHARNEY DS; HOFFER PB; INNIS RB; BRADBERRY CW
      MICRODIALYSIS AND SPECT MEASUREMENTS OF AMPHETAMINE-INDUCED DOPAMINE RELEASE IN NONHUMAN-PRIMATES

      Synapse
    72. SCANLEY BE; KENNAN RP; CANNAN S; SKUDLARSKI P; INNIS RB; GORE JC
      FUNCTIONAL MAGNETIC-RESONANCE-IMAGING OF MEDIAN NERVE-STIMULATION IN RATS AT 2.0 T

      Magnetic resonance in medicine
    73. ABIDARGHAM A; INNIS RB; WISNIEWSKI G; BALDWIN RM; NEUMEYER JL; SEIBYL JP
      HUMAN BIODISTRIBUTION AND DOSIMETRY OF IODINE-123-FLUOUOALKYL ANALOGSOF BETA-CIT

      European journal of nuclear medicine
    74. SEIBYL JP; MAREK K; SHEFF K; BALDWIN RM; ZOGHBI S; ZEAPONCE Y; CHARNEY DS; VANDYCK CH; HOFFER PB; INNIS RB
      TEST RETEST REPRODUCIBILITY OF IODINE-123-BETA-CIT SPECT BRAIN MEASUREMENT OF DOPAMINE TRANSPORTERS IN PARKINSONS PATIENTS/

      The Journal of nuclear medicine
    75. FUJITA M; WOODS SW; ABIDARGHAM A; JATLOW P; BALDWIN RM; ZOGHBI SS; SEIBYL JP; RAJEEVAN N; WHITE JA; KRYSTAL JH; INNIS RB
      CHANGE OF BENZODIAZEPINE RECEPTOR DURING CHRONIC BENZODIAZEPINE ADMINISTRATION IN HEALTHY-HUMAN SUBJECTS

      The Journal of nuclear medicine
    76. FUJITA M; ALTIKRITI MS; SEIBYL JP; BALDWIN RM; ZOGHBI SS; BURGER C; VERHOEFF NP; RAJEEVAN N; CHARNEY DS; INNIS RB
      IMAGING OF DOPAMINE D2 3 RECEPTORS WITH [I-123] EPIDEPRIDE - KINETIC AND EQUILIBRIUM STUDIES/

      The Journal of nuclear medicine
    77. LARUELLE M; ABIDARGHAM A; GIL R; KRYSTAL J; SEIBYL J; BALDWIN R; INNIS RB
      IMPACT OF THE CHOICE OF OUTCOME MEASURE ON THE SPECT MEASUREMENT OF D2 RECEPTORS IN SCHIZOPHRENIA

      The Journal of nuclear medicine
    78. VANDYCK CH; TAN PZ; BALDWIN RM; RAMSBY Q; RICH DA; GARG PK; NG CK; SOUFER R; CHARNEY DS; INNIS RB
      PET QUANTIFICATION OF 5-HT2A C RECEPTORS IN THE HUMAN BRAIN - A CONSTANT INFUSION PARADIGM WITH [F-18] ALTANSERIN/

      The Journal of nuclear medicine
    79. ZOGHBI SS; TAMAGNAN G; BALDWIN RM; GAO Y; NEUMEYER JL; BALDESSARINI R; CHARNEY DS; SEIBYL JS; INNIS RB
      SYNTHESIS OF A DOPAMINE TRANSPORTER BINDING CYCLO-PENTADIENE PHENYLTROPANE CONJUGATE COMPLEXED WITH RE AND TC-99M

      The Journal of nuclear medicine
    80. BALDWIN RM; ALTIKRITI M; ZEAPONCE Y; ZOGHBI SS; EFANGE S; CHARNEY DS; INNIS RB
      SYNTHESIS AND MONKEY SPECT IMAGING OF THE PUTATIVE VESAMICOL RECEPTOR-BINDING RADIOTRACER [I-123] (-MIBT())

      The Journal of nuclear medicine
    81. RAJEEVAN N; INNIS RB; RAMSBY Q; ZOGHBI SS; SEIBYL JP; ZUBAL IG
      EVALUATION OF NONUNIFORM ATTENUATION CORRECTION IN QUANTITATIVE BRAINSPECT IMAGING

      The Journal of nuclear medicine
    82. TAN PZ; BALDWIN RM; VANDYCK CH; AMICI L; ALTIKRITI M; ROTH B; KHAN N; FOWLER JS; SHEA C; SOUFER R; CHARNEY DS; INNIS RB
      IDENTITY AND RECEPTOR-BINDING OF RADIOMETABOLITES OF THE 5-HT2A 2C LIGAND [F-18] ALTANSERIN/

      The Journal of nuclear medicine
    83. ABIDARGHAM A; ZEAPONCE Y; TERRIER D; ALTIKRITI M; BALDWIN RM; HOFFER P; CHARNEY D; LEYSEN JE; LARUELLE M; MERTENS J; INNIS RB
      PRECLINICAL EVALUATION OF [I-123] R93274 AS A SPECT RADIOTRACER FOR IMAGING 5-HT2A RECEPTORS

      European journal of pharmacology
    84. BREMNER JD; RANDALL P; VERMETTEN E; STAIB L; BRONEN RA; MAZURE C; CAPELLI S; MCCARTHY G; INNIS RB; CHARNEY DS
      MAGNETIC-RESONANCE IMAGING-BASED MEASUREMENT OF HIPPOCAMPAL VOLUME INPOSTTRAUMATIC-STRESS-DISORDER RELATED TO CHILDHOOD PHYSICAL AND SEXUAL ABUSE - A PRELIMINARY-REPORT

      Biological psychiatry
    85. BREMNER JD; INNIS RB; SALOMON RM; STAIB LH; NG CK; MILLER HL; BRONEN RA; KRYSTAL JH; DUNCAN J; RICH D; PRICE LH; MALISON R; DEY H; SOUFER R; CHARNEY DS
      POSITRON EMISSION TOMOGRAPHY MEASUREMENT OF CEREBRAL METABOLIC CORRELATES OF TRYPTOPHAN DEPLETION-INDUCED DEPRESSIVE RELAPSE

      Archives of general psychiatry
    86. BREMNER JD; INNIS RB; NG CK; STAIB LH; SALOMON RM; BRONEN RA; DUNCAN J; SOUTHWICK SM; KRYSTAL JH; RICH D; ZUBAL G; DEY H; SOUFER R; CHARNEY DS
      POSITRON EMISSION TOMOGRAPHY MEASUREMENT OF CEREBRAL METABOLIC CORRELATES OF YOHIMBINE ADMINISTRATION IN COMBAT-RELATED POSTTRAUMATIC-STRESS-DISORDER

      Archives of general psychiatry
    87. VANDYCK CH; SEIBYL JP; STUBBS JB; ZOGHBI S; WISNIEWSKI G; BALDWIN RM; ZEAPONCE Y; CHARNEY DS; HOFFER PB; INNIS RB
      HUMAN BIODISTRIBUTION AND DOSIMETRY OF THE SPECT D-2 DOPAMINE-RECEPTOR RADIOLIGAND [I-123] IBF

      Nuclear medicine and biology
    88. ELSWORTH JD; BRITTAN MS; TAYLOR JR; SLADEK JR; ALTIKRITI MS; ZEAPONCE Y; INNIS RB; REDMOND DE; ROTH RH
      RESTORATION OF DOPAMINE TRANSPORTER DENSITY IN THE STRIATUM OF FETAL VENTRAL MESENCEPHALON-GRAFTED, BUT NOT SHAM-GRAFTED, MPTP-TREATED PARKINSONIAN MONKEYS

      Cell transplantation
    89. LARUELLE M; ABIDARGHAM A; GIL R; VANDYCK CH; ERDOS J; DSOUZA D; ROSENBLATT W; MCCANCEKATZ E; ZEAPONCE Y; ZOGHBI SS; BALDWIN RM; HOFFER PB; KRYSTAL J; CHARNEY DS; INNIS RB
      SPECT IMAGING OF SYNAPTIC DOPAMINE RELEASE IN DRUG-FREE SCHIZOPHRENIC-PATIENTS - AN EXPERIMENTAL VALIDATION OF THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA

      Schizophrenia research
    90. ABIDARGHAM A; GANDELMAN MS; DEERAUSQUIN GA; ZEAPONCE Y; ZOGHBI SS; BALDWIN RM; LARUELLE M; CHARNEY DS; HOFFER PB; NEUMEYER JL; INNIS RB
      SPECT IMAGING OF DOPAMINE TRANSPORTERS IN HUMAN BRAIN WITH IODINE-123-FLUOROALKYL ANALOGS OF BETA-CIT

      The Journal of nuclear medicine
    91. LARUELLE M; DSOUZA CD; ZOGHBI SS; BALDWIN RM; CHARNEY DS; INNIS RB
      SPECT MEASUREMENT OF DOPAMINE SYNAPTIC CONCENTRATION IN THE RESTING STATE

      The Journal of nuclear medicine
    92. LARUELLE M; ABIDARGHAM A; GIL R; ERDOS J; DSOUZA CD; ZOGHBI SS; BALDWIN RM; SEIBYL JP; KRYSTAL J; CHARNEY DS; INNIS RB
      SPECT MEASUREMENT OF DOPAMINE TRANSPORTERS IN SCHIZOPHRENIA

      The Journal of nuclear medicine
    93. LARUELLE M; VANDYCK CH; ABIDARGHAM A; ROSENBLATT W; ZOGHBI SS; BALDWIN RM; HOFFER PB; CHARNEY DS; INNIS RB
      AGE-RELATED DECLINE IN AMPHETAMINE-INDUCED DOPAMINE RELEASE MEASURED WITH SPECT AND [123I]IBZM IN HEALTHY-SUBJECTS

      The Journal of nuclear medicine
    94. MALISON RT; BEST S; ZOGHBI SS; ZEAPONCE Y; BALDWIN RM; CHARNEY DS; HOFFER PB; SEIBYL J; PRICE LH; KOSTEN TR; INNIS RB
      SPECT IMAGING OF DOPAMINE TRANSPORTERS DURING SUSTAINED COCAINE ABSTINENCE WITH [I-123] BETA-CIT

      The Journal of nuclear medicine
    95. BREMNER JD; INNIS RB; STAIB L; NG CK; RICH D; DEY H; SOUFER R; CHARNEY DS
      PET FDG MEASUREMENT OF CEREBRAL METABOLIC CORRELATES OF DEPRESSIVE RELAPSE

      The Journal of nuclear medicine
    96. VANDYCK CH; SEIBYL JP; LARUELLE M; BEST S; SHEFF K; MAREK KL; MALISON RT; ZOGHBI SS; ZEAPONCE Y; BALDWIN RM; CHARNEY DS; HOFFER PB; INNIS RB
      AGING EFFECTS WITH [I-123] BETA-CIT SPECT - ANALYSIS OF GENDER, STRIATAL SUBREGION, AND NEUROPSYCHOLOGICAL CORRELATES

      The Journal of nuclear medicine
    97. ABIDARGHAM A; KRYSTAL J; WEBB E; ZOGHBI S; LARUELLE M; PETRAKIS I; BALDWIN RM; HOFFER PB; CHARNEY DS; INNIS RB
      SPECT IMAGING OF BENZODIAZEPINE RECEPTORS IN ALCOHOLICS AND HEALTHY CONTROLS

      The Journal of nuclear medicine
    98. SEIBYL JP; LARUELLE M; VANDYCK CH; WALLACE E; BALDWIN RM; ZOGHBI S; ZEAPONCE Y; NEUMEYER JL; CHARNEY DS; HOFFER PB; INNIS RB
      REPRODUCIBILITY OF IODINE-123-BETA-CIT SPECT BRAIN MEASUREMENT OF DOPAMINE TRANSPORTERS

      The Journal of nuclear medicine
    99. VANDYCK CH; SEIBYL JP; ZUBAL G; INNIS RB
      QUANTITATION OF NEURORECEPTORS - A NEED TO INCREASE IMAGING RESOLUTION - REPLY

      The Journal of nuclear medicine
    100. SEIBYL JP; ZEAPONCE Y; BRENNER L; BALDWIN RM; KRYSTAL JH; OFFORD SJ; MOCHOVIAK S; CHARNEY DS; HOFFER PB; INNIS RB
      CONTINUOUS INTRAVENOUS-INFUSION OF IODINE-123-IBZM FOR SPECT DETERMINATION OF HUMAN BRAIN DOPAMINE-RECEPTOR OCCUPANCY BY ANTIPSYCHOTIC AGENT RWJ-37796

      The Journal of nuclear medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 04:03:04